Glycogen synthase kinase-3β: A mediator of inflammation in Alzheimer's disease?

International Journal of Alzheimer's Disease

Volumn , Issue , 2011, Pages

  Koistinaho, Jari ^a,b   Malm, Tarja ^a   Goldsteins, Gundars ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1; MIXED LINEAGE KINASE 3; MONOCYTE CHEMOTACTIC PROTEIN 1; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; BRAIN FUNCTION; CELL ACTIVATION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CYTOKINE PRODUCTION; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; MICROGLIA; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW;

EID: 79959260656     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.4061/2011/129753     Document Type: Review

References (120)

1. Hardy J. A., Higgins G. A., Alzheimer's disease: the amyloid cascade hypothesis Science 1992 256 5054 184 185
2. Crouch P. J., Harding S. M. E., White A. R., Camakaris J., Bush A. I., Masters C. L., Mechanisms of A mediated neurodegeneration in Alzheimer's disease International Journal of Biochemistry and Cell Biology 2008 40 2 181 198 (Pubitemid 350137874)
3. Michelucci A., Heurtaux T., Grandbarbe L., Morga E., Heuschling P., Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: effects of oligomeric and fibrillar amyloid-β Journal of Neuroimmunology 2009 210 1-2 3 12
4. Heneka M. T., O'Banion M. K., Terwel D., Kummer M. P., Neuroinflammatory processes in Alzheimer's disease Journal of Neural Transmission 2010 117 8 919 947
5. Eikelenboom P., Van Gool W. A., Neuroinflammatory perspectives on the two faces of Al'zheimer's disease Journal of Neural Transmission 2004 111 3 281 294 (Pubitemid 38316606)
6. Eikelenboom P., Zhan S. S., Van Gool W. A., Allsop D., Inflammatory mechanisms in Alzheimer's disease Trends in Pharmacological Sciences 1994 15 12 447 450 (Pubitemid 24379277)
7. McGeer P. L., McGeer E. G., The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases Brain Research Reviews 1995 21 2 195 218 (Pubitemid 26061873)
8. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G. M., Cooper N. R., Eikelenboom P., Emmerling M., Fiebich B. L., Finch C. E., Frautschy S., Griffin W. S. T., Hampel H., Hull M., Landreth G., Lue L. F., Mrak R., MacKenzie I. R., McGeer P. L., O'Banion M. K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., Van Muiswinkel F. L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., Wyss-Coray T., Inflammation and Alzheimer's disease Neurobiology of Aging 2000 21 3 383 421 (Pubitemid 30349107)
9. McGeer P. L., McGeer E. G., Inflammation, autotoxicity and Alzheimer disease Neurobiology of Aging 2001 22 6 799 809 (Pubitemid 34066546)
10. Bamberger M. E., Harris M. E., McDonald D. R., Husemann J., Landreth G. E., A cell surface receptor complex for fibrillar -amyloid mediates microglial activation Journal of Neuroscience 2003 23 7 2665 2674 (Pubitemid 36418601)
11. Malm T. M., Koistinaho M., Prepalo M., Vatanen T., Ooka A., Karlsson S., Koistinaho J., Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to -amyloid deposition in APP/PS1 double transgenic Alzheimer mice Neurobiology of Disease 2005 18 1 134 142 (Pubitemid 40092904)
12. Ransohoff R. M., Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology Immunity 2009 31 5 711 721
13. Hanisch U. K., Kettenmann H., Microglia: active sensor and versatile effector cells in the normal and pathologic brain Nature Neuroscience 2007 10 11 1387 1394 (Pubitemid 350014685)
14. Hanisch U. K., Microglia as a source and target of cytokines GLIA 2002 40 2 140 155
15. Gorlovoy P., Larionov S., Pham T. T. H., Neumann H., Accumulation of tau induced in neurites by microglial proinflammatory mediators FASEB Journal 2009 23 8 2502 2513
16. Koistinaho M., Koistinaho J., Role of p38 and p44/42 mitogen-activated protein kinases in microglia GLIA 2002 40 2 175 183 (Pubitemid 35337375)
17. Koistinaho M., Koistinaho J., Interactions between Alzheimer's disease and cerebral ischemia-Focus on inflammation Brain Research Reviews 2005 48 2 240 250 (Pubitemid 40585755)
18. Lue L. F., Yan S. D., Stern D. M., Walker D. G., Preventing activation of receptor for advanced glycation endproducts in Alzheimer's disease Current Drug Targets 2005 4 3 249 266 (Pubitemid 40754161)
19. Beurel E., Jope R. S., Glycogen synthase kinase-3 regulates inflammatory tolerance in astrocytes Neuroscience 2010 69 3 1063 1070
20. Beurel E., Michalek S. M., Jope R. S., Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3) Trends in Immunology 2010 31 1 24 31
21. Woodgett J. R., Molecular cloning and expression of glycogen synthase kinase-3/factor A EMBO Journal 1990 9 8 2431 2438
22. Mukai F., Ishiguro K., Sano Y., Fujita S. C., Aternative splicing isoform of tau protein kinase I/glycogen synthase kinase 3 Journal of Neurochemistry 2002 81 5 1073 1083 (Pubitemid 34809290)
23. Solovjov D. A., Pluskota E., Plow E. F., Distinct roles for the and subunits in the functions of integrin β Journal of Biological Chemistry 2005 280 2 1336 1345
24. Schaffer B., Wiedau-Pazos M., Geschwind D. H., Gene structure and alternative splicing of glycogen synthase kinase 3 beta (GSK-3 ) in neural and non-neural tissues Gene 2003 302 1-2 73 81 (Pubitemid 36078399)
25. Wood-Kaczmar A., Kraus M., Ishiguro K., Philpott K. L., Gordon-Weeks P. R., An alternatively spliced form of glycogen synthase kinase-3 is targeted to growing neurites and growth cones Molecular and Cellular Neuroscience 2009 42 3 184 194
26. Hur E.-M., Zhou F.-Q., GSK3 signalling in neural development Nature Reviews Neuroscience 2010 11 8 539 551
27. Castao Z., Gordon-Weeks P. R., Kypta R. M., The neuron-specific isoform of glycogen synthase kinase-3 is required for axon growth Journal of Neurochemistry 2010 113 1 117 130
28. Owen R., Gordon-Weeks P. R., Inhibition of glycogen synthase kinase 3 in sensory neurons in culture alters filopodia dynamics and microtubule distribution in growth cones Molecular and Cellular Neuroscience 2003 23 4 626 637 (Pubitemid 36970223)
29. Yoshimura T., Kawano Y., Arimura N., Kawabata S., Kikuchi A., Kaibuchi K., GSK-3 regulates phosphorylation of CRMP-2 and neuronal polarity Cell 2005 120 1 137 149 (Pubitemid 40094609)
30. Farooqui R., Zhu S., Fenteany G., Glycogen synthase kinase-3 acts upstream of ADP-ribosylation factor 6 and Rac1 to regulate epithelial cell migration Experimental Cell Research 2006 312 9 1514 1525
31. Kim W. Y., Wang X., Wu Y., Doble B. W., Patel S., Woodgett J. R., Snider W. D., GSK-3 is a master regulator of neural progenitor homeostasis Nature Neuroscience 2009 12 11 1390 1397
32. Bultje R. S., Castaneda-Castellanos D. R., Jan L. Y., Jan Y. N., Kriegstein A. R., Shi S. H., Mammalian par3 regulates progenitor cell asymmetric division via notch signaling in the developing neocortex Neuron 2009 63 2 189 202
33. Kwok J. B. J., Hallupp M., Loy C. T., Chan D. K. Y., Woo J., Mellick G. D., Buchanan D. D., Silburn P. A., Halliday G. M., Schofield P. R., GSK3B polymorphisms alter transcription and splicing in Parkinson's disease Annals of Neurology 2005 58 6 829 839 (Pubitemid 41746872)
34. Kwok J. B. J., Loy C. T., Hamilton G., Lau E., Hallupp M., Williams J., Owen M. J., Broe G. A., Tang N., Lam L., Powell J. F., Lovestone S., Schofield P. R., Glycogen synthase kinase-3 and tau genes interact in Alzheimer's disease Annals of Neurology 2008 64 4 446 454
35. Shin J., Yu S.-B., Yu U. Y., Jo S. A., Ahn J.-H., Swedish mutation within amyloid precursor protein modulates global gene expression towards the pathogenesis of Alzheimer's disease BMB Reports 2010 43 10 704 709
36. Avila J., Wandosell F., Hernndez F., Role of glycogen synthase kinase-3 in Alzheimer's disease pathogenesis and glycogen synthase kinase-3 inhibitors Expert Review of Neurotherapeutics 2010 10 5 703 710
37. Mao Y., Ge X., Frank C. L., Madison J. M., Koehler A. N., Doud M. K., Tassa C., Berry E. M., Soda T., Singh K. K., Biechele T., Petryshen T. L., Moon R. T., Haggarty S. J., Tsai LI. H., Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3 / -Catenin Signaling Cell 2009 136 6 1017 1031
38. Beurel E., Jope R. S., Lipopolysaccharide-induced interleukin-6 production is controlled by glycogen synthase kinase-3 and STAT3 in the brain Journal of Neuroinflammation 2009 6, article 9
39. Yuskaitis C. J., Jope R. S., Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity Cellular Signalling 2009 21 2 264 273
40. Ding Y., Qiao A., Fan G. H., Indirubin-3'-monoxime rescues spatial memory deficits and attenuates -amyloid-associated neuropathology in a mouse model of Alzheimer's disease Neurobiology of Disease 2010 39 2 156 168
41. Huang W. C., Lin Y. S., Wang C. Y., Tsai C. C., Tseng H. C., Chen C. L., Lu P. J., Chen PO. S., Qian LI., Hong J. S., Lin C. F., Glycogen synthase kinase-3 negatively regulates anti-inflammatory interleukin-10 for lipopolysaccharide-induced iNOS/NO biosynthesis and RANTES production in microglial cells Immunology 2009 128 1, supplement e275 e286
42. Malm T., Koistinaho M., Muona A., Magga J., Koistinaho J., The role and therapeutic potential of monocytic cells in Alzheimer's disease GLIA 2010 58 8 889 900
43. Choi J., Zheng Q., Katz H. E., Guilarte T. R., Silica-based nanoparticle uptake and cellular response by primary microglia Environmental Health Perspectives 2010 118 5 589 595
44. Reed-Geaghan E. G., Savage J. C., Hise A. G., Landreth G. E., CD14 and toll-like receptors 2 and 4 are required for fibrillar A -stimulated microglial activation Journal of Neuroscience 2009 29 38 11982 11992
45. Koronyo-Hamaoui M., Ko M. K., Koronyo Y., Azoulay D., Seksenyan A., Kunis G., Pham M., Bakhsheshian J., Rogeri P., Black K. L., Farkas D. L., Schwartz M., Attenuation of AD-like neuropathology by harnessing peripheral immune cells: local elevation of IL-10 and MMP-9 Journal of Neurochemistry 2009 111 6 1409 1424
46. Yamamoto M., Kiyota T., Walsh S. M., Liu J., Kipnis J., Ikezu T., Cytokine-mediated inhibition of fibrillar amyloid- peptide degradation by human mononuclear phagocytes Journal of Immunology 2008 181 6 3877 3886
47. Teixeira A. L., Reis H. J., Coelho F. M., Carneiro D. S., Teixeira M. M., Vieira L. B., Mukhamedyarov M. A., Zefirov A. L., Janka Z., Palots A., All-or-nothing type biphasic cytokine production of human lymphocytes after exposure to Alzheimer's -Amyloid peptide Biological Psychiatry 2008 64 10 891 895
48. Reale M., Iarlori C., Feliciani C., Gambi D., Peripheral chemokine receptors, their ligands, cytokines and Alzheimer's disease Journal of Alzheimer's Disease 2008 14 2 147 159 (Pubitemid 352040032)
49. Wang M.-J., Huang H.-Y., Chen W.-F., Chang H.-F., Kuo J.-S., Glycogen synthase kinase-3 inactivation inhibits tumor necrosis factor- production in microglia by modulating nuclear factor B and MLK3/JNK signaling cascades Journal of Neuroinflammation 2010 31 1 99
50. Chatzigeorgiou A., Lyberi M., Chatzilymperis G., Nezos A., Kamper E., CD40/CD40L signaling and its implication in health and disease BioFactors 2009 35 6 474 483
51. Ono T., Yanagawa Y., Iwabuchi K., Nonomura K., Ono K., Glycogen synthase kinase 3 activity during development of bone marrow-derived dendritic cells (DCs) essential for the DC function to induce T helper 2 polarization Immunology 2007 122 2 189 198 (Pubitemid 47389947)
52. Li Q., Michaud M., Canosa S., Kuo A., Madri J. A., GSK-3 : a signaling pathway node modulating neural stem cell and endothelial cell interactions. Angiogenesis, 2011, In press
53. Neumann H., Linnartz B., Wang Y., Microglial immunoreceptor tyrosine-based activation and inhibition motif signaling in neuroinflammation International Journal of Alzheimer's Disease 2010 2010 7
54. Rogers J., Lue L. F., Microglial chemotaxis, activation, and phagocytosis of amyloid -peptide as linked phenomena in Alzheimer's disease Neurochemistry International 2001 39 5-6 333 340 (Pubitemid 32907397)
55. Tuppo E. E., Arias H. R., The role of inflammation in Alzheimer's disease International Journal of Biochemistry and Cell Biology 2005 37 2 289 305 (Pubitemid 39330191)
56. Heneka M. T., O'Banion M. K., Inflammatory processes in Alzheimer's disease Journal of Neuroimmunology 2007 184 1-2 69 91 (Pubitemid 46365992)
57. Abbas N., Bednar I., Mix E., Marie S., Paterson D., Ljungberg A., Morris C., Winblad B., Nordberg A., Zhu J., Up-regulation of the inflammatory cytokines IFN- and IL-12 and down-regulation of IL-4 in cerebral cortex regions of APP transgenic mice Journal of Neuroimmunology 2002 126 1-2 50 57 (Pubitemid 34521731)
58. Bezzi P., Domercq M., Brambilla L., Galli R., Schols D., De Clercq E., Vescovi A., Bagetta G., Kollias G., Meldolesi J., Volterra A., CXCR4-activated astrocyte glutamate release via TNFa: amplification by microglia triggers neurotoxicity Nature Neuroscience 2001 4 7 702 710 (Pubitemid 32595408)
59. Bezzi P., Domercq M., Vesce S., Volterra A., Neuron-astrocyte cross-talk during synaptic transmission: physiological and neuropathological implications Progress in Brain Research 2001 132 255 265
60. Brown G. C., Bal-Price A., Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria Molecular Neurobiology 2003 27 3 325 355 (Pubitemid 38156291)
61. Blasko I., Marx F., Steiner E., Hartmann T., Grubeck-Loebenstein B., TNF plus IFN induce the production of alzheimer -amyloid peptides and decrease the secretion of APPs FASEB Journal 1999 13 1 63 68 (Pubitemid 29038275)
62. Griffin W. S. T., IL-1 and the cytokine cycle in Alzheimers disease Journal of Neurochemistry 2000 74 S52
63. Mrak R. E., Griffin W. S. T., Interleukin-1, neuroinflammation, and Alzheimer's disease Neurobiology of Aging 2001 22 6 903 908 (Pubitemid 34066557)
64. Wyss-Coray T., Lin C., Yan F., Yu G. Q., Rohde M., Mcconlogue L., Masliah E., Mucke L., TGF- 1 promotes microglial amyloid- clearance and reduces plaque burden in transgenic mice Nature Medicine 2001 7 5 612 618 (Pubitemid 32448330)
65. Kiyota T., Okuyama S., Swan R. J., Jacobsen M. T., Gendelman H. E., Ikezu T., CNS expression of anti-inflammatory cytokine interleukin-4 attenuates Alzheimer's disease-like pathogenesis in APP+PS1 bigenic mice FASEB Journal 2010 24 8 3093 3102
66. Hu S., Chao C. C., Ehrlich L. C., Sheng W. S., Sutton R. L., Rockswold G. L., Peterson P. K., Inhibition of microglial cell RANTES production by IL-10 and TGF- Journal of Leukocyte Biology 1999 65 6 815 821 (Pubitemid 29279531)
67. Moore K. W., De Waal Malefyt R., Coffman R. L., O'Garra A., Interleukin-10 and the interleukin-10 receptor Annual Review of Immunology 2001 19 683 765 (Pubitemid 32368050)
68. Shimizu E., Kawahara K., Kajizono M., Sawada M., Nakayama H., IL-4-induced selective clearance of oligomeric -amyloid peptide(142) by rat primary type 2 microglia Journal of Immunology 2008 181 9 6503 6513
69. Benveniste E. N., Nguyen V. T., O'Keefe G. M., Immunological aspects of microglia: relevance to Alzheimer's disease Neurochemistry International 2001 39 5-6 381 391 (Pubitemid 32907402)
70. Hao J., Wang Z. D., Yang Y. X., Study on -amyloid peptide 142 induced chemokine rantes in U251 cell Journal of Sichuan University 2009 40 6 1011 1014
71. Didonato J. A., Hayakawa M., Rothwarf D. M., Zandi E., Karin M., A cytokine-responsive I B kinase that activates the transcription factor NF- B Nature 1997 388 6642 548 554 (Pubitemid 27339997)
72. Karin M., Ben-Neriah Y., Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity Annual Review of Immunology 2000 18 621 663 (Pubitemid 30365393)
73. Hanada T., Yoshimura A., Regulation of cytokine signaling and inflammation Cytokine and Growth Factor Reviews 2002 13 4-5 413 421
74. Morris K. R., Lutz R. D., Choi H. S., Kamitani T., Chmura K., Chan E. D., Role of the NF- B signaling pathway and B cis-regulatory elements on the IRF-1 and iNOS promoter regions in mycobacterial lipoarabinomannan induction of nitric oxide Infection and Immunity 2003 71 3 1442 1452 (Pubitemid 36254331)
75. Vermeulen L., De Wilde G., Notebaert S., Vanden Berghe W., Haegeman G., Regulation of the transcriptional activity of the nuclear factor- B p65 subunit Biochemical Pharmacology 2002 64 5-6 963 970 (Pubitemid 35232270)
76. Hayden M. S., Ghosh S., Signaling to NF-B Genes and Development 2004 18 18 2195 2224
77. Schmitz M. L., Mattioli I., Buss H., Kracht M., NF- B: a multifaceted transcription factor regulated at several levels ChemBioChem 2004 5 10 1348 1358 (Pubitemid 39371504)
78. Gong R., Rifai A., Ge Y., Chen S., Dworkin L. D., Hepatocyte growth factor suppresses proinflammatory NF B activation through GSK3 inactivation in renal tubular epithelial cells Journal of Biological Chemistry 2008 283 12 7401 7410
79. Chen L. F., Mu Y., Greene W. C., Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF- B EMBO Journal 2002 21 23 6539 6548 (Pubitemid 35448431)
80. Kiernan R., Brs V., Ng R. W. M., Coudart M. P., El Messaoudi S., Sardet C., Jin D. Y., Emiliani S., Benkirane M., Post-activation turn-off of NF- B-dependent transcription is regulated by acetylation of p65 Journal of Biological Chemistry 2003 278 4 2758 2766 (Pubitemid 36801357)
81. Coyle-Rink J., Del Valle L., Sweet T., Khalili K., Amini S., Developmental expression of Wnt signaling factors in mouse brain Cancer Biology amp; Therapy 2002 1 6 640 645
82. Duan Y., Liao A. P., Kuppireddi S., Ye Z., Ciancio M. J., Sun J., β-Catenin activity negatively regulates bacteria-induced inflammation Laboratory Investigation 2007 87 6 613 624 (Pubitemid 46788789)
83. Li H. L., Wang H. H., Liu S. J., Phosphorylation of tau antagonizes apoptosis by stabilizing beta-catenin, a mechanism involved in Alzheimer's neurodegeneration Proceedings of the National Academy of Sciences of the United States of America 2007 104 9 3591 3596
84. Halleskog C., Mulder J., Dahlstrm J., Mackie K., Hortobgyi T., Tanila H., Kumar Puli L., Frber K., Harkany T., Schulte G., WNT signaling in activated microglia is proinflammatory GLIA 2011 59 1 119 131
85. Takada Y., Fang X., Jamaluddin M. S., Boyd D. D., Aggarwal B. B., Genetic deletion of glycogen synthase kinase-3 abrogates activation of I B kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor Journal of Biological Chemistry 2004 279 38 39541 39554 (Pubitemid 39258221)
86. Leung I. W. L., Lassam N., Dimerization via tandem leucine zippers is essential for the activation of the mitogen-activated protein kinase kinase kinase, MLK-3 Journal of Biological Chemistry 1998 273 49 32408 32415 (Pubitemid 28557612)
87. Shen F., Zhao M. W., He B., Yang J. J., Pei F., Wang Y. Z., The changes and significance of interleukin-17 in rat models of chronic obstructive pulmonary disease and asthma Zhonghua Jie He He Hu Xi Za Zhi 2004 27 10 654 658
88. Shen E., Fan J., Peng T., Glycogen synthase kinase-3beta suppresses tumor necrosis factor-alpha expression in cardiomyocytes during lipopolysaccharide stimulation Journal of Cellular Biochemistry 2008 104 1 329 338
89. Vines A., Cahoon S., Goldberg I., Saxena U., Pillarisetti S., Novel anti-inflammatory role for glycogen synthase kinase-3 in the inhibition of tumor necrosis factor- -and interleukin-1 -induced inflammatory gene expression Journal of Biological Chemistry 2006 281 25 16985 16990
90. Bard F., Cannon C., Barbour R., Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease Nature Medicine 2000 6 8 916 919 (Pubitemid 30644751)
91. Schenk D., Barbour R., Dunn W., Gordon G., Grajeda H., Guldo T., Hu K., Huang J., Johnson-Wood K., Khan K., Kholodenko D., Lee M., Liao Z., Lieberburg I., Motter R., Mutter L., Soriano F., Shopp G., Vasquez N., Vandevert C., Walker S., Wogulis M., Yednock T., Games D., Seubert P., Immunization with amyloid- attenuates Alzheimer disease-like pathology in the PDAPP mouse Nature 1999 400 6740 173 177 (Pubitemid 29327547)
92. Reed-Geaghan E. G., Savage J. C., Hise A. G., Landreth G. E., CD14 and toll-like receptors 2 and 4 are required for fibrillar A -stimulated microglial activation Journal of Neuroscience 2009 29 38 11982 11992
93. Kielian T., Toll-like receptors in central nervous system glial inflammation and homeostasis Journal of Neuroscience Research 2006 83 5 711 730
94. Pfeiffer A., Bttcher A., Ors E., Kapinsky M., Nagy P., Bodnr A., Spreitzer I., Liebisch G., Drobnik W., Gempel K., Horn M., Holmer S., Hartung T., Multhoff G., Schtz G., Schindler H., Ulmer A. J., Heine H., Stelter F., Schtt C., Rothe G., Szlli J., Damjanovich S., Schmitz G., Lipopolysaccharide and ceramide docking to CD14 provokes ligand-specific receptor clustering in rafts European Journal of Immunology 2001 31 11 3153 3164 (Pubitemid 33100507)
95. Triantafilou M., Gamper F. G. J., Haston R. M., Mouratis M. A., Morath S., Hartung T., Triantafilou K., Membrane sorting of toll-like receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting Journal of Biological Chemistry 2006 281 41 31002 31011 (Pubitemid 44582155)
96. Triantafilou M., Morath S., Mackie A., Hartung T., Triantafilou K., Lateral diffusion of Toll-like receptors reveals that they are transiently confined within lipid rafts on the plasma membrane Journal of Cell Science 2004 117 17 4007 4014 (Pubitemid 39207336)
97. McDonald D. R., Brunden K. R., Landreth G. E., Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia Journal of Neuroscience 1997 17 7 2284 2294 (Pubitemid 27137396)
98. Combs C. K., Johnson D. E., Cannady S. B., Lehman T. M., Landreth G. E., Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of -amyloid and prion proteins Journal of Neuroscience 1999 19 3 928 939 (Pubitemid 29066155)
99. Koenigsknecht J., Landreth G., Microglial phagocytosis of fibrillar -amyloid through a integrin-dependent mechanism Journal of Neuroscience 2004 24 44 9838 9846 (Pubitemid 39463564)
100. Wilkinson B., Koenigsknecht-Talboo J., Grommes C., Lee C. Y., Landreth G., Fibrillar beta-amyloid-stimulated intracellular signaling cascades require Vav for induction of respiratory burst and phagocytosis in monocytes and microglia The Journal of Biological Chemistry 2006 281 30 20842 20850 (Pubitemid 44115425)
101. Frank S., Copanaki E., Burbach G. J., Mller U. C., Deller T., Differential regulation of toll-like receptor mRNAs in amyloid plaque-associated brain tissue of aged APP23 transgenic mice Neuroscience Letters 2009 453 1 41 44
102. Tahara K., Kim H. D., Jin J. J., Maxwell J. A., Li L., Fukuchi K., Role of toll-like receptor signalling in Abeta uptake and clearance Brain 2006 129 11 3006 3019 (Pubitemid 44684521)
103. Richard K. L., Filali M., Prfontaine P., Rivest S., Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid and delay the cognitive decline in a mouse model of Alzheimer's disease Journal of Neuroscience 2008 28 22 5784 5793
104. Fiala M., Liu P. T., Espinosa-Jeffrey A., Rosenthal M. J., Bernard G., Ringman J. M., Sayre J., Zhang L., Zaghi J., Dejbakhsh S., Chiang B., Hui J., Mahanian M., Baghaee A., Hong P., Cashman J., Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin Proceedings of the National Academy of Sciences of the United States of America 2007 104 31 12849 12854 (Pubitemid 47255243)
105. Martin M., Rehani K., Jope R. S., Michalek S. M., Toll-like receptormediated cytokine production is differentially regulated by glycogen synthase kinase 3 Nature Immunology 2005 6 8 777 784 (Pubitemid 43090463)
106. Tan J., Town T., Crawford F., Mori T., DelleDonne A., Crescentini R., Obregon D., Flavel R. A., Mullan M. J., Role of CD40 ligand in amyloidosis in transgenic Alzheimer's mice Nature Neuroscience 2002 5 12 1288 1293 (Pubitemid 35417763)
107. Laporte V., Lombard Y., Levy-Benezra R., Tranchant C., Poindron P., Warter J. -M., Uptake of A 140- and A 142-coated yeast by microglial cells: a role for LRP Journal of Leukocyte Biology 2004 76 2 451 461 (Pubitemid 39006960)
108. Town T., Nikolic V., Tan J., The microglial activation continuum: from innate to adaptive responses Journal of Neuroinflammation 2005 2, article 24
109. Terwel D., Muyllaert D., Dewachter I., Borghgraef P., Croes S., Devijver H., Van Leuven F., Amyloid activates GSK-3 to aggravate neuronal tauopathy in bigenic mice American Journal of Pathology 2008 172 3 786 798 (Pubitemid 351354550)
110. Muyllaert D., Kremer A., Jaworski T., Borghgraef P., Devijver H., Croes S., Dewachter I., Van Leuven F., Glycogen synthase kinase-3, or a link between amyloid and tau pathology? Genes, Brain and Behavior 2008 7 supplement 1 57 66
111. Li H. L., Wang H. H., Liu S. J., Phosphorylation of tau antagonizes apoptosis by stabilizing beta-catenin, a mechanism involved in Alzheimer's neurodegeneration Proceedings of the National Academy of Sciences of the United States of America 2007 104 9 3591 3596
112. Leroy K., Yilmaz Z., Brion J. P., Increased level of active GSK-3 in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration Neuropathology and Applied Neurobiology 2007 33 1 43 55 (Pubitemid 46090309)
113. Takashima A., GSK-3 is essential in the pathogenesis of Alzheimer's disease Journal of Alzheimer's Disease 2006 9 supplement 3 309 317 (Pubitemid 44253325)
114. Mateo I., Infante J., Llorca J., Rodrguez E., Berciano J., Combarros O., Association between glycogen synthase kinase-3 genetic polymorphism and late-onset Alzheimer's disease Dementia and Geriatric Cognitive Disorders 2006 21 4 228 232
115. Bustanji Y., Taha M. O., Almasri I. M., Al-Ghussein M. A. S., Mohammad M. K., Alkhatib H. S., Inhibition of glycogen synthase kinase by curcumin: Investigation by simulated molecular docking and subsequent in vitro/in vivo evaluation Journal of Enzyme Inhibition and Medicinal Chemistry 2009 24 3 771 778
116. Lim G. P., Chu T., Yang F., Beech W., Frautschy S. A., Cole G. M., The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse Journal of Neuroscience 2001 21 21 8370 8377 (Pubitemid 33051435)
117. Lim G. P., Yang F., Chu T., Chen P., Beech W., Teter B., Tran T., Ubeda O., Ashe K. H., Frautschy S. A., Cole G. M., Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease Journal of Neuroscience 2000 20 15 5709 5714 (Pubitemid 30636898)
118. Greenspan E. J., Madigan J. P., Boardman L. A., Rosenberg D. W., Ibuprofen inhibits activation of nuclear β-catenin in human colon adenomas and induces the phosphorylation of GSK-3 β Cancer Prevention Research 2011 4 1 161 171
119. Malm T. M., Iivonen H., Goldsteins G., Keksa-Goldsteine V., Ahtoniemi T., Kanninen K., Salminen A., Auriola S., Van Groen T., Tanila H., Koistinaho J., Pyrrolidine dithiocarbamate activates Akt and improves spatial learning in APP/PS1 mice without affecting -amyloid burden Journal of Neuroscience 2007 27 14 3712 3721 (Pubitemid 46557689)
120. Nurmi A., Goldsteins G., Nrvinen J., Pihlaja R., Ahtoniemi T., Grhn O., Koistinaho J., Antioxidant pyrrolidine dithiocarbamate activates Akt-GSK signaling and is neuroprotective in neonatal hypoxia-ischemia Free Radical Biology and Medicine 2006 40 10 1776 1784